Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Switzerland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091
20121
20131
20141
20153
20162
20173
20182
20201
20212
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Recruiting3
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Basilea Pharmaceutica2
Swiss Cancer Institute2
University Hospital, Basel, Switzerland2
Adherex Technologies, Inc.1
AstraZeneca1
Bayer1
BeiGene USA, Inc.1
Celgene1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms24
Melanoma7
Sarcoma4
Carcinoma, Non-Small-Cell Lung3
Glioblastoma3
Neoplasm Metastasis3
Breast Neoplasms2
Carcinoma, Ovarian Epithelial2
Central Nervous System Neoplasms2
Colonic Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.